Healthcare AI investors focused on Pharma / Therapeutics

Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Pharma / Therapeutics within healthcare AI. Includes lead investors, follow-on participants, and active angels.

The therapeutics sector focuses on the scientific research, clinical development, and commercialization of chemical or biological compounds used to treat diseases. Venture investment in this space is heavily milestone-driven, guiding novel drugs from early pre-clinical laboratory research through rigorous, multi-phase human clinical trials to ultimate regulatory approval.
339 investors match

Within Pharma / Therapeutics: top investment stages

Series A (235) Seed (231) Series B (160) Growth (142) Pre-Seed (102) Series C (89) Series D+ (38) Post-IPO (2)
Korea Development Bank
PE T3
Seoul, South Korea
$25M+
Korea Development Bank is a state-owned policy bank headquartered in Seoul that provides large, anchor-style capital across the Korean economy, including biotechnology…
Biotech Pharma / Therapeutics
Korea Investment Corporation
PE T3
Seoul, South Korea
$25M+
Korea Investment Corporation is the sovereign wealth fund of South Korea, managing approximately $200 billion in assets across global public equities, fixed…
Biotech Pharma / Therapeutics
KTB Network
VC T3
Seoul, South Korea
$5M-$25M
KTB Network, now operating as Daol Investment, is a Seoul-based venture and growth investor with a long history in Korean and broader…
Biotech Pharma / Therapeutics
Leafy Tunnel
VC T3
London, United Kingdom
$250k-$1M
Leafy Tunnel is a UK-based early-stage venture fund focused on backing companies that develop alternative therapeutics for mental health and chronic conditions,…
Biotech Care Delivery / Tech-Enabled Services
Legend Capital
VC T3
Beijing, China
$10M-$30M
Legend Capital is a Beijing-based venture firm with a long-running healthcare practice spanning biotech, medical devices, and pharma and therapeutics. The firm…
Biotech Medical Devices / MedTech
Life Sciences Innovative Manufacturing Fund
VC T3
London, United Kingdom
$25M+
The Life Sciences Innovative Manufacturing Fund is a major UK government intervention administered through the Department for Science, Innovation and Technology, providing…
Biotech Life Sciences Tools
Life Sciences Transformational R&D Investment Fund
VC T3
London, United Kingdom
$25M+
The Life Sciences Transformational R&D Investment Fund is a pilot UK sovereign capital program administered through the Department for Science, Innovation and…
Biotech Diagnostics
Lifeforce Capital
VC T3
San Francisco, United States
$250k-$1M
Lifeforce Capital presents as an early-stage venture investor with a thesis tilt toward longevity, performance health, and consumer biology, though detailed public…
AI/ML in Healthcare Biotech
LifeX Ventures
VC T3
New York, United States
$1M-$5M
LifeX Ventures positions as a longevity and human-performance focused investor, backing companies at the intersection of biology, consumer health, and software. With…
AI/ML in Healthcare Biotech
Ligand Pharmaceuticals
PE T3
Jupiter, United States
$5M-$25M
Ligand Pharmaceuticals is a publicly traded biopharmaceutical company that operates a royalty-driven business model around licensed drug programs, captive technology platforms, and…
Biotech Pharma / Therapeutics
Lightspeed Venture Partners
VC T1
Menlo Park, United States
unknown
Lightspeed Venture Partners is one of the largest multi-stage firms in the world, with offices in the US, India, China, Europe, Israel,…
AI/ML in Healthcare Biotech
Lightstone Ventures
VC T3
Menlo Park, United States
unknown
Lightstone Ventures is a Boston- and Bay Area-anchored healthcare venture firm investing across biotech, medical devices, and digital health, with the resources…
Biotech Medical Devices / MedTech
Lilly Asia Ventures
VC AI T3
Shanghai, China
$5M-$25M
Lilly Asia Ventures occupies an unusual position in the global biopharma capital landscape. Despite the name and origin, the firm operates as…
Biotech Diagnostics
Lilly Ventures
Corporate VC T3
Indianapolis, United States
$1M-$5M
Lilly Ventures has historically operated as Eli Lilly’s corporate venture arm, with later iterations rebranded under Lilly Asia Ventures and other vehicles…
Biotech Health IT / Healthcare Software
Linden Capital Partners
PE T3
Chicago, United States
$25M+
Linden Capital Partners is a Chicago-based private equity firm that invests exclusively in healthcare and life sciences, executing leveraged buyouts in middle-market…
Medical Devices / MedTech Pharma / Therapeutics
AI Tool Finder
AI-powered search. Results may not be comprehensive.